Using the Blood Thinner Low-Molecular-Weight-Heparin Improves Outcomes After Heart Attacks

Armen Hareyan's picture
Advertisement

In the largest angiographic study to date assessing low-molecular-weight-heparin (LMWH) versus standard unfractionated heparin (UFH) as a "blood thinner" for patients who have experienced a heart attack, researchers from Brigham and Women's Hospital (BWH) found more evidence that LMWH improves blood flow and patient outcomes after a heart attack.

Advertisement